Post written by Douglas G. Adler, MD, FACG, AGAF, FASGE, from the Center for Advanced Therapeutic Endoscopy, Centura Health, Denver, Colorado, USA, and incoming GIE Editor-in-Chief. We analyzed the U.S. Food and Drug Administration’s Manufacturer and User Facility Device Experience (MAUDE) database for all reports of patient-related adverse events and device failures associated with the 3 …
Tag: adverse events
Comparison of 22-gauge standard and Franseen needles in EUS-guided tissue acquisition for diagnosing solid pancreatic lesions: a multicenter randomized controlled trial
Post written by Masahiro Itonaga, MD, and Masayuki Kitano, MD, PhD, from the Second Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan. To the best of our knowledge, no large multicenter randomized controlled trials (RCTs) have compared EUS-guided tissue acquisition (EUS-TA) using standard needles and Franseen needles for the diagnosis of solid pancreatic lesions. …
Editor’s Choice: Novel classification for adverse events in GI endoscopy: the AGREE classification
GIE Senior Associate Editor and incoming Editor-in-Chief Douglas G. Adler, MD, FASGE, highlights this article from the June issue: “Novel classification for adverse events in GI endoscopy: the AGREE classification” by Karlijn J. Nass, MD, et al. Several classification systems for evaluating and grading adverse events have been developed over the years, but none have received widespread …
Novel classification for adverse events in GI endoscopy: the AGREE classification
Post written by Paul Fockens, MD, PhD, from the Department of Gastroenterology and Hepatology, Research Institute Amsterdam Gastroenterology & Metabolism, Amsterdam University Medical Center, Amsterdam, The Netherlands. Our research showed that there is no commonly used classification for adverse events in GI endoscopy (AGREE). We developed and tested a new classification based on a universally …
Continue reading Novel classification for adverse events in GI endoscopy: the AGREE classification
Evaluating the impact of frailty on periprocedural adverse events and mortality among patients with GI bleeding
Post written by Camilo J. Acosta, MD David Goldberg, MD Sunil Amin, MD, MPH, from the Department of Medicine, University of Miami/Jackson Memorial Hospital, Miami, Florida, USA and Division of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, Miami, Florida, USA. Frailty is common and has been extensively studied as a …
Distance from hospital impacts adverse event detection
Post written by Rajesh N. Keswani, MD, MS, from the Northwestern University Feinberg School of Medicine. The objective of this study was to determine the hospital utilization patterns of patients with endoscopy-related adverse events (AEs), including death, after ambulatory endoscopy at 5 Chicago-area medical centers. We specifically aimed to investigate whether care fragmentation, which is …
Continue reading Distance from hospital impacts adverse event detection
Predicting adverse events associated with therapeutic colonoscopy
Post written by Ryota Niikura , MD, PhD from the Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo Our study focused on a large sample size of various therapeutic colonoscopies and data on the use of drugs that might increase the risk of bleeding, such as anticoagulants and antithrombotics, NSAIDs, and steroids. …
Continue reading Predicting adverse events associated with therapeutic colonoscopy
Prediction of adverse events after esophageal stent placement
Lorenzo Fuccio, MD, from the Department of Medical and Surgical Sciences, S.Orsola-Malpighi University Hospital, in Bologna, Italy discusses this Original Article, "Development of a prediction model of adverse events after stent placement for esophageal cancer." We conducted a retrospective analysis of a large database including 267 patients with dysphagia owing to esophageal cancer and treated …
Continue reading Prediction of adverse events after esophageal stent placement
endoscopedia.com 